Study group | Mean age | Number of patients |
---|---|---|
Epithelial ovarian cancer patients | 62,35 | 40 |
○ Serous | 63,9 | 31 |
○ Endometrioid | 60,66 | 6 |
○ Mucinous | 49,66 | 3 |
FIGO I, II | 53.3 | 10 |
FIGO III, IV | 65.37 | 30 |
Grading 1 | 52 | 7 |
Grading 2 | 63.4 | 9 |
Grading 3 | 61.96 | 24 |
Other gynecological and non- gynecological conditions | 41,98 | 82 |
○ Functional cysts | 45,14 | 21 |
○ Ovarian endometrioma | 35,71 | 14 |
○ Mature teratoma | 28 | 9 |
○ Borderline epithelial tumors | 41,78 | 9 |
○ Benign epithelial and gonadal tumors | 50,69 | 16 |
○ Myoma | 42,4 | 5 |
○ Inflammation | 37,5 | 4 |
○ Cirrhosis | 47,75 | 4 |
Other malignant neoplasms | 56,24 | 17 |
○ Lymphoma | 41 | 1 |
○ Malignant GCT | 65,5 | 2 |
○ Breast cancer | 56 | 4 |
○ Cervical cancer | 43,6 | 3 |
○ Endometrial cancer | 61,3 | 3 |
○ Stomach cancer | 61,5 | 4 |